MetLife Investment Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $170K | Buy |
17,001
+2,958
| +21% | +$29.5K | ﹤0.01% | 2276 |
|
|
2025
Q1 | $83.8K | Hold |
14,043
| – | – | ﹤0.01% | 2598 |
|
|
2024
Q4 | $108K | Hold |
14,043
| – | – | ﹤0.01% | 2585 |
|
|
2024
Q3 | $143K | Hold |
14,043
| – | – | ﹤0.01% | 2460 |
|
|
2024
Q2 | $208K | Buy |
14,043
+1,365
| +11% | +$20.3K | ﹤0.01% | 2216 |
|
|
2024
Q1 | $173K | Hold |
12,678
| – | – | ﹤0.01% | 2272 |
|
|
2023
Q4 | $139K | Hold |
12,678
| – | – | ﹤0.01% | 2437 |
|
|
2023
Q3 | $139K | Hold |
12,678
| – | – | ﹤0.01% | 2408 |
|
|
2023
Q2 | $168K | Hold |
12,678
| – | – | ﹤0.01% | 2385 |
|
|
2023
Q1 | $173K | Hold |
12,678
| – | – | ﹤0.01% | 2305 |
|
|
2022
Q4 | $248K | Hold |
12,678
| – | – | ﹤0.01% | 2114 |
|
|
2022
Q3 | $242K | Hold |
12,678
| – | – | ﹤0.01% | 2159 |
|
|
2022
Q2 | $261K | Hold |
12,678
| – | – | ﹤0.01% | 2123 |
|
|
2022
Q1 | $408K | Buy |
12,678
+4,679
| +58% | +$151K | ﹤0.01% | 1898 |
|
|
2021
Q4 | $372K | Hold |
7,999
| – | – | ﹤0.01% | 1664 |
|
|
2021
Q3 | $216K | Hold |
7,999
| – | – | ﹤0.01% | 2041 |
|
|
2021
Q2 | $205K | Hold |
7,999
| – | – | ﹤0.01% | 2162 |
|
|
2021
Q1 | $273K | Buy |
7,999
+3,036
| +61% | +$104K | ﹤0.01% | 1873 |
|
|
2020
Q4 | $168K | Hold |
4,963
| – | – | ﹤0.01% | 2075 |
|
|
2020
Q3 | $122K | Buy |
+4,963
| New | +$122K | ﹤0.01% | 2118 |
|